Kercheville Advisors’s Apollo Endosurgery, Inc. APEN Stock Holding History

Kercheville Advisors’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-10,682	Closed	-$97K	–	126
2021 Q3	$97K	Hold	10,682	–	–	0.05%	110
2021 Q2	$87K	Hold	10,682	–	–	0.04%	117
2021 Q1	$59K	Buy	+10,682	New	+$52.8K	0.03%	116

Other funds holding APEN

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Kercheville Advisors's APEN Position: Q4 2021 in Review

Kercheville Advisors sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2021, closing a stake of 10,682 shares — an estimated $97K sold.

Kercheville Advisors first reported a position in APEN in Q1 2021 and held it in 3 quarters. The position peaked at $97K in Q3 2021. 72 funds tracked by Wall St. Rank hold APEN as of Q4 2021.

Kercheville Advisors reported no remaining Apollo Endosurgery, Inc. position as of Q4 2021 after selling out during the quarter.
Kercheville Advisors sold 10,682 Apollo Endosurgery, Inc. shares in Q4 2021, an estimated $97K.
Kercheville Advisors first reported a position in Apollo Endosurgery, Inc. in Q1 2021 and held it in 3 quarters.
Kercheville Advisors's Apollo Endosurgery, Inc. position peaked at $97K in Q3 2021.
72 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2021.

Based on Kercheville Advisors's 13F filing for Q4 2021, filed 26 Jan 2022.